Relationship between Antimalarial Drug Activity, Accumulation, and Inhibition of Heme Polymerization in Plasmodium falciparum In Vitro
|
|
- Robyn Peters
- 6 years ago
- Views:
Transcription
1 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Mar. 1998, p Vol. 42, No /98/$ Copyright 1998, American Society for Microbiology Relationship between Antimalarial Drug Activity, Accumulation, and Inhibition of Heme Polymerization in Plasmodium falciparum In Vitro SHAUN R. HAWLEY, 1 PATRICK G. BRAY, 2 MATHIRUT MUNGTHIN, 2 JILL D. ATKINSON, 2 PAUL M. O NEILL, 2 AND STEPHEN A. WARD 2 * Department of Pharmacology and Therapeutics 2 and Department of Human Anatomy and Cell Biology, 1 University of Liverpool, Liverpool L69 3BX, United Kingdom Received 25 September 1997/Returned for modification 5 November 1997/Accepted 10 December 1997 We have investigated the contribution of drug accumulation and inhibition of heme polymerization to the in vitro activities of a series of antimalarial drugs. Only those compounds exhibiting structural relatedness to the quinolines inhibited heme polymerization. We could find no direct correlation between in vitro activity against chloroquine-susceptible or chloroquine-resistant isolates and either inhibition of heme polymerization or cellular drug accumulation for the drugs studied. However, in vitro activity against a chloroquine-susceptible isolate but not a chloroquine-resistant isolate showed a significant correlation with inhibition of heme polymerization when the activity was normalized for the extent of drug accumulation. The importance of these observations to the rational design of new quinoline-type drugs and the level of agreement of these conclusions with current views on quinoline drug action and resistance are discussed. The malarial parasite Plasmodium falciparum digests a large proportion of its host cell hemoglobin during its erythrocytic cycle, presumably as a source of essential nutrients (24, 25, 28). Digestion is a complex process involving three proteases: one cysteine protease (falcipain) and two aspartic proteases (plasmepsins I and II) (22). Digestion is thought to be initiated by the action of plasmepsin I on native hemoglobin, leading to the release of iron II ferroprotoporphyrin IX (FPIX) (12). Free FPIX is a toxic substance, and parasites which are lacking in heme oxygenase are unable to detoxify free FPIX by metabolism. Instead, malarial parasites have evolved an autocatalytic detoxification process in which FPIX is oxidized to iron III FPIX (hematin), which is then polymerized, forming inert crystals of hemozoin or malaria pigment (8). Following early observations that free FPIX was able to form complexes with nitrogenous bases such as pyridines and quinolines (6, 18, 23) it was hypothesized that the quinolinecontaining antimalarial agents exerted their effects by forming toxic complexes with free FPIX released in situ (5). More recent work has shown that quinoline antimalarial agents are able to inhibit the spontaneous polymerization of hematin, suggesting a mechanism by which free FPIX or FPIX-chloroquine (CQ) complexes may concentrate in the food vacuole and kill the parasite (8, 26). There is strong evidence that the accumulation of quinolinecontaining drugs is influenced by the physicochemical properties of the drugs and the proton gradient which exists between the external environment and the intracellular parasite (2, 19). Such factors profoundly influence the local drug concentration in the food vacuole and therefore the ability of a drug to inhibit heme polymerization in situ. Indeed, studies carried out in this laboratory have clearly indicated that the extent of accumulation of quinoline-containing drugs is an important determinant of their activity (14, 15). In the present study, using a series of * Corresponding author. Mailing address: Department of Pharmacology and Therapeutics, University of Liverpool, P.O. Box 147, Liverpool L69 3BX, United Kingdom. Phone: Fax: saward@liv.ac.uk. 27 antimalarial agents (14 quinolines and 13 nonquinolines), we have tested the relative contribution of drug accumulation and inhibition of heme polymerization activity to in vitro antiparasitic drug activity against CQ-resistant and -susceptible isolates of P. falciparum. MATERIALS AND METHODS Drugs used in the study. CQ, amodiaquine (AQ), mepacrine (MEP), quinine (QN), quinidine (QND), cinchonine (CIN), cinchonidine (CIND), and primaquine (PQ) were purchased from Sigma, Dorset, United Kingdom. 7-Chloro- 4-(4 -pyrollidino-1 -methylbutamino)quinoline (chloroquine-pyrollidinyl; CQ- PYROL), monodesethyl chloroquine (DesCQ), and bidesethyl chloroquine (BidesCQ) were obtained from The Walter Reed Army Institute, Washington, D.C. Monodesethyl amodiaquine (DesAQ), bidesethyl amodiaquine (BidesAQ), amopyroquine (AMOPYR), and tebuquine (TBQ) were obtained from Parke- Davis Limited, Hampshire, United Kingdom. Pyronaridine (PYR) was a gift from D. Warhurst, London School of Hygiene and Tropical Medicine. Halofantrine (HF) was from SmithKline Beecham; mefloquine (MQ) was obtained from Roche; and artemether (ARM), arteether (ART), and dihydroartemisinine (DHA) were provided by the World Health Organization. 4-[3 -[(Diethylamino)methyl]-4 -hyroxyanilino]pyridine (AQ-PYRID), 4-(diethylamino-1 methylbutylamino)pyridine (CQ-PYRID), 7-chloro-4-(3 -t-butylaminomethyl- 4 -hydroxyanilino) quinoline (N-t-butyl amodiaquine; NTB-AQ), 4 -dehydroxytebuquine (4-deOH TBQ), 4 -dehydroxy-4 -fluorotebuquine (4F-TBQ), and 7-chloro-4-hydroxyanilinoquinoline (De-SC-AQ) were synthesized as reported previously (13, 20). The chemical structures of all the drugs are shown in Fig. 1. Parasite isolates and maintenance and preparation of isolates. Four isolates of P. falciparum were used in this study. Isolates 3D7 and HB3 were CQsusceptible isolates, and isolate K1 was a CQ-resistant isolate; these isolates were obtained from D. Walliker, University of Edinburgh, Edinburgh, United Kingdom. Isolate PH3, a CQ-resistant isolate, was obtained from M. Hommel, Liverpool School of Tropical Medicine, Liverpool, United Kingdom. Cultures, which were maintained by an adaptation of the method of Jensen and Trager (16), consisted of a 1 to 5% suspension of type O-positive erythrocytes in complete culture medium (RPMI 1640 medium supplemented with 10% human type AB serum, 25 mm HEPES buffer, and 23 mm NaHCO 3 ). These cultures were gassed with an atmosphere of 93% N 2,3%CO 2, and 4% O 2. Cultures were synchronized by the method of Lambros and Vandenburg (17) before use. Drug susceptibility assays. Drug potency was assessed by an adaptation of the standard 48-h microdilution technique described by Desjardins et al. (7). Parasites were exposed to serial dilutions of drug over 48 h, and growth was assessed by comparing the level of incorporation of [G- 3 H]hypoxanthine by the parasites, at each drug concentration, with that of an appropriate control. Dose-response curves were then plotted by using the Grafit software package (Erithacus Software, Staines, United Kingdom). The 50% inhibitory concentrations (IC 50 s) were calculated graphically by interpolation of the dose-response curve. Assays were carried out with an inoculum size of 1 to minimize any inoculum effect 682
2 VOL. 42, 1998 HEME POLYMERIZATION IN P. FALCIPARUM 683 FIG. 1. Chemical structures of the compounds used in this study. Downloaded from associated with the IC 50 of the drug. Results are given as the means of at least three separate experiments. Measurement of drug accumulation and absolute drug activity using inoculum effect analysis. The measured IC 50 of a drug increases with increased inoculum size (where inoculum size level of parasitemia hematocrit) due to significant depletion of drug from the medium (10). This phenomenon is termed the inoculum effect. In this study, the potencies of the compounds studied were assessed at inoculum sizes ranging from 1 to 10 (fractional parasite volume, to 0.001). Over this range, the relationship between measured IC 50 of the drug and inoculum size is linear. Extrapolation of this line to an inoculum size of zero provides a measure of absolute drug potency from the following equation (10): IC 50 measured IC 50 absolute (IC 50 absolute accumulation ratio fractional volume of PRBCs), where PRBCs are parasitized erythrocytes. Furthermore, we have previously validated the use of this mathematical relationship for the determination of the cellular drug accumulation ratio (CAR) from the following equation (3): CAR (IC 50 measured IC 50 absolute )/(IC 50 absolute fractional volume of PRBCs), where CAR is the ratio of the amount of drug in the infected cell pellet to the amount of drug in a similar volume of medium. This approach allows the measurement of accumulation in the absence of radioactively labelled drug. Heme polymerization assay. The ability of the compounds studied to inhibit heme polymerization was assessed by a modification of the protocol reported by Dorn et al. (8). Incubations were performed in 1.5-ml Eppendorf tubes containing 50 g of -hematin, 140 M 14 C-hemin chloride (specific activity, 105 Ci mol 1 ; University of Leeds Innovations Industrial Services Ltd., Leeds, United Kingdom), and test drug at the appropriate concentration in a 100- l final volume of 500 mm sodium acetate buffer (ph 4.8). The samples were then incubated at 37 C overnight. Appropriate drug-free and radioactive background controls were included. Following incubation, unreacted -hematin was removed by incubating the samples in 2% sodium dodecyl sulfate (1 ml in 0.1 M sodium bicarbonate buffer [ph 9.1]) at 37 C for 15 min. The samples were centrifuged (14,000 g, 15 min) and the supernatant was removed, and the cell pellet was washed by subsequent incubation (37 C, 15 min) and centrifugation (14,000 g, 15 min) steps with 1 ml of 0.1 M sodium bicarbonate buffer (ph 9.1) and then 1 ml of 50 mm Tris-HCl (ph 7.5). Finally, 100 l of 0.1 M NaOH was added to resuspend the cell pellet, and the samples were transferred to liquid scintillation vials containing 100 l of glacial acetic acid. Following the addition of 4 ml of Optiphase Safe liquid scintillant, samples were counted on a Rackbeta 1219 liquid scintillation counter. Mean disintegrations per minute are expressed as percent inhibition relative to the amount of hemozoin formation in a drug-free control. Dose-response curves were plotted with the Grafit software package (Erithacus Software). IC 50 s were calculated graphically by interpolation of the dose-response curve. Results are given as the means of at least three separate experiments. RESULTS The heme polymerization inhibitory potentials and antimalarial activities (at an inoculum size of 1) of the drugs against each of the four parasite isolates are presented in Table 1. Ignoring the data obtained for the sesquiterpene lactones ARM, ART, and DHA and the 8-aminoquinoline PQ (which are considered to have independent mechanisms of action), the drugs tested showed greater than 2,000- and 5,000-fold ranges in their antimalarial activities (IC 50 ) against the CQsusceptible and the CQ-resistant isolates, respectively. The equivalent ranges for the 14 quinoline compounds were 300- fold against the CQ-susceptible isolates and 200-fold against the CQ-resistant isolates. In contrast, there was only a 10-fold difference in the heme polymerization inhibitory activities of the compounds studied. No heme polymerization inhibitory activity could be measured for the sesquiterpene lactones ARM, ART, and DHA or the 8-aminoquinoline PQ within the range of drug solubility. There was no correlation between the inhibition of heme on April 28, 2018 by guest
3 684 HAWLEY ET AL. ANTIMICROB. AGENTS CHEMOTHER. TABLE 1. IC 50 s for heme polymerization and antimalarial drug potencies Drug IC 50 ( M) for heme polymerization Antimalarial drug potency (IC 50 [nm] at an inoculum size of 1) 3D7 HB3 K1 PH3 AQ CQ DesAQ BidesAQ DesCQ BidesCQ , ,256.3 AMOPYR PYR MEP TBQ deOH TBQ F-TBQ NTB-AQ CQ-PYROL AQ-PYRID , ,298.0 CQ-PYRID , , , ,612.3 De-SC-AQ , , , ,139.3 QN QND CIN CIND HF MQ ARM 1, ART 1, DHA 1, PQ 1,000 ND a ND ND ND a ND, not determined. polymerization and antiparasitic activity (measured at an inoculum size of 1) whether these were considered against each parasite isolate alone or against all isolates (all r values for correlations between the IC 50 for heme polymerization and the IC 50 of the antiparasitic drug at an inoculum size of 1 against isolates 3D7, HB3, K1, and PH3 were 0.25; P, 0.28). Table 2 presents the results obtained from inoculum effect experiments involving a more limited series of quinoline compounds. There was a 50-fold range in the absolute antimalarial activities (IC 50 s) and an 80-fold range in the CARs of the drugs tested against CQ-susceptible isolate 3D7. The values for CQresistant isolate K1 were 20- and 10-fold, respectively. Again, there was no obvious correlation between inhibition of heme polymerization and the absolute IC 50 of the drug for either the 3D7 or the K1 isolate (r, 0.21; P, 0.65 in each case). Similarly, there was no significant correlation between the inhibition of heme polymerization and CAR for either the 3D7 or the K1 isolate (r, 0.53; P, 0.23 in each case). It has been shown previously (14) that drug accumulation plays a pivotal role in the antimalarial potencies of quinolines. To account for the role of drug accumulation in the potencies of antimalarial drugs, we have normalized the absolute IC 50 for CAR (measured by inoculum effect analysis) for each compound. For isolates 3D7 and K1 the CAR for each drug studied has been normalized to that of the drug with the highest CAR for each isolate. These normalized levels of drug accumulation have then been multiplied by the corresponding absolute IC 50 of each compound. These calculated accumulationnormalized IC 50 s (Table 2) have been correlated with the IC 50 of heme polymerase (Fig. 2A and B). There is a significant TABLE 2. Absolute antimalarial drug potencies and CARs derived from inoculum effect analysis and accumulation-normalized absolute IC 50 s of drugs a Drug Absolute antimalarial drug potency (IC 50 [nm]) CAR Accumulation-normalized IC 50 of the drug (arbitrary units) 3D7 K1 3D7 K1 3D7 K1 AQ ,955 3, CQ ,768 1, DesAQ ,250 3, NTB-AQ ,171 14, AMOPYR ,173 12, TBQ ,456 14, F-TBQ , a The accumulation-normalized absolute IC 50 s of various drugs (for isolates 3D7 and K1) were calculated by normalizing the CAR for each drug studied to that for the drug with the highest CAR for each isolate. These normalized levels of drug accumulation have then been multiplied by the corresponding absolute IC 50 of each compound.
4 VOL. 42, 1998 HEME POLYMERIZATION IN P. FALCIPARUM 685 FIG. 2. Correlation of heme polymerase IC 50 and accumulation-normalized absolute drug IC 50 (calculated for isolates 3D7 and K1 by normalizing the CAR for each drug studied to that for the drug with the highest CAR for each isolate). These normalized levels of drug accumulation have then been multiplied by the corresponding absolute IC 50 of each compound for isolates 3D7 (r 0.81; P 0.026) (A) and K1 (r 0.17; P 0.72) (B). correlation between the accumulation-normalized IC 50 and the heme polymerase IC 50 for the CQ-susceptible isolate (Fig. 2A; r 0.81; P 0.026) but not the CQ-resistant isolate (Fig. 2B; r 0.17; P 0.72). DISCUSSION Considerable experimental evidence suggests that inhibition of heme polymerization is central to the mechanism of action of the quinoline-containing antimalarial agents (9). However, recent evidence from this laboratory indicates that the extent of drug accumulation at the site of heme polymerization is also a regulator of antimalarial activity (4, 14). Earlier studies investigating the simple relationship between activity and inhibition of heme polymerization with a limited number of drug substrates have produced contradictory findings (21, 26). In the present study we have undertaken a detailed analysis of the antimalarial activities and heme polymerization inhibitory activities of 27 antimalarial drugs. In addition, we have extended our investigations to consider the relative contribution of drug accumulation to the inhibition of heme polymerization and in vitro antiparasitic activities of drugs against CQ-resistant and -susceptible isolates of P. falciparum. Although CAR represents total parasite accumulation, all available evidence suggests that most of this occurs at the level of the acid food vacuole. This assumption is based on the acidic ph of this organelle and the vacuolar generation of sites where the drug binds to heme. Within the range of solubility achievable, no heme polymerization inhibitory activity could be measured for the sesquiterpene lactones ART, ARM, and DHA or for the 8-aminoquinoline PQ. These results are unsurprising, given that these compounds have mechanisms of action that are distinct from those of the other classes of antimalarial drugs studied. The present study failed to demonstrate any clear relationship between antiparasitic activity and inhibition of heme polymerization for any of the isolates studied. This was true even if the 4-aminoquinolines are considered in isolation. It is clear that a number of compounds, such as CQ-PYRID, AQ- PYRID, and De-SC-AQ, have very limited activity against either CQ-susceptible or CQ-resistant isolates of P. falciparum yet are potent inhibitors of heme polymerization (Table 1). Therefore, although the polymerization inhibition assay identifies compounds whose chemistry lends itself well to inhibition of heme polymerization, this does not in itself guarantee antimalarial activity. The reason for such a discrepancy is the requirement for these antimalarial drugs to accumulate to very high concentrations within the parasite. The commonly used antimalarial agents CQ (11) and AQ (15) accumulate to high concentrations within the malaria parasite, and this ability to accumulate to such high concentrations is fundamental to their ability to inhibit parasite growth. Previous studies from this laboratory have also indicated that the levels of accumulation of a series of 4-aminoquinoline antimalarial agents is related to their ability to inhibit parasite growth (14). CQ and AQ are able to accumulate to micromolar concentrations within the whole parasite and most probably to millimolar concentrations within the acid food vacuole of the parasite (the site of hemoglobin digestion and heme polymerization) (1, 15). Interestingly, as can be seen from Table 1, the majority of the compounds studied here inhibit heme polymerization over a narrow range of micromolar concentrations. We argue, therefore, that the principal difference between the quinolines which show good antiparasitic activity in vitro and those that do not is a reflection of their ability to accumulate within the parasite rather than their ability to inhibit polymerization. This argument is supported by the correlation between the accumulation-normalized antimalarial activity and heme polymerization observed with CQ-susceptible isolate 3D7 (Fig. 2A). We have demonstrated recently that resistant isolates have a mechanism which reduces the local concentration of CQ at the heme binding site (4, 27). This results in a high proportion of the total CQ uptake into resistant isolates being nonspecific or nonpharmacologically active. Thus, total drug accumulation is not well correlated with activity in resistant isolates for drugs which are recognized by the verapamil-sensitive resistance mechanism, including CQ, AQ, and DesAQ. This explains the lack of correlation of normalized antimalarial activity with heme polymerization observed with isolate K1, which is highly CQ resistant (Fig. 2B). In conclusion, the antimalarial activities of quinoline-type drugs are a function of both the ability of the drug to interfere with the polymerization process and the ability of the drug to accumulate to pharmacologically relevant concentrations at the site of drug action. The heme polymerase assay is useful as a screening assay for agents whose chemistries lend themselves to the inhibition of heme polymerization, but it is clearly not a predictor of antimalarial activity in vitro. The development of novel aminoquinolines with improved pharmacological characteristics will require an understanding of both those features of the molecule essential for interaction with the polymerization process and those features which control the rate and extent of drug accumulation at the intraparasitic site of drug action.
5 686 HAWLEY ET AL. ANTIMICROB. AGENTS CHEMOTHER. ACKNOWLEDGMENTS This work was supported by a research program grant from The Wellcome Trust. S.A.W. is in receipt of a Wellcome Trust Research Leave Fellowship. REFERENCES 1. Bray, P. G., M. K. Boulter, G. Y. Ritchie, and S. A. Ward Relationship of global chloroquine transport and reversal of chloroquine resistance in P. falciparum. Mol. Biochem. Parasitol. 63: Bray, P. G., S. R. Hawley, M. Mungthin, and S. A. Ward Physicochemical properties correlated with drug resistance and the reversal of drug resistance in Plasmodium falciparum. Mol. Pharmacol. 50: Bray, P. G., S. R. Hawley, and S. A. Ward Aminoquinoline resistance of Plasmodium falciparum: insights from the study of amodiaquine uptake. Mol. Pharmacol. 50: Bray, P. G., M. Mungthin, R. Ridley, and S. A. Ward. Submitted for publication. 5. Chou, A. C., and C. D. Fitch Haemolysis of mouse erythrocytes by ferriprotoporphyrin IX and chloroquine. Chemotherapeutic implications. J. Clin. Invest. 66: Cohen, S. N., K. O. Phifer, and K. L. Yielding Complex formation between chloroquine and ferrihaemic acid in vitro and its effect on the antimalarial action of chloroquine. Nature 202: Desjardins, R. E., J. Canfield, D. Haynes, and J. D. Chulay Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16: Dorn, A., R. Stoffel, H. Matile, A. Bubendorf, and R. Ridley Malarial haemozoin/ -haematin supports the polymerisation of haem in the absence of protein. Nature 374: Foley, M., and L. Tilley Quinoline antimalarials: mechanisms of action and resistance. Int. J. Parasitol. 27: Geary, T. G., A. D. Divo, J. B. Jensen, M. Zangwill, and H. Ginsburg Kinetic modelling of the response of Plasmodium falciparum to chloroquine and its experimental testing in vitro. Implications for mechanism of action and resistance to the drug. Biochem. Pharmacol. 40: Geary, T. G., J. B. Jensen, and H. Ginsburg Uptake of 3 H chloroquine by drug-sensitive and -resistant strains of the human malarial parasite Plasmodium falciparum. Biochem. Pharmacol. 35: Goldberg, D. E., and A. F. G. Slater The pathway of hemoglobin degradation in malaria parasites. Parasitol. Today 8: Hawley, S. R., P. G. Bray, P. M. O Neill, D. J. Naisbitt, B. K. Park, and S. A. Ward Manipulation of the N-alkyl substituent in amodiaquine to overcome the verapamil-sensitive chloroquine resistance component. Antimicrob. Agents Chemother. 40: Hawley, S. R., P. G. Bray, P. M. O Neill, B. K. Park, and S. A. Ward The role of drug accumulation in 4-aminoquinoline antimalarial potency the influence of structural substitution and physicochemical properties. Biochem. Pharmacol. 52: Hawley, S. R., P. G. Bray, B. K. Park, and S. A. Ward Amodiaquine accumulation in Plasmodium falciparum as a possible explanation for its superior antimalarial activity over chloroquine. Mol. Biochem. Parasitol. 80: Jensen, J. B., and W. Trager Plasmodium falciparum in culture: use of outdated erythrocytes and description of the candle-jar method. J. Parasitol. 63: Lambros, C., and J. P. Vandenburg Synchronisation of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65: Macomber, P. B., H. Sprinz, and A. J. Tousimis Morphological effects of chloroquine on Plasmodium berghei in mice. Nature 214: Martiney, J. A., A. Cerami, and A. F. G. Slater Verapamil reversal of chloroquine resistance in the malaria parasite Plasmodium falciparum is specific for resistant parasites and independent of the weak base effect. J. Biol. Chem. 270: O Neill, P. M., D. J. Willock, S. R. Hawley, P. G. Bray, R. C. Storr, S. A. Ward, and B. K. Park Synthesis, antimalarial activity, and molecular modeling of tebuquine analogues. J. Med. Chem. 40: Raynes, K., M. Foley, L. Tilley, and L. W. Deady Novel bisquinoline antimalarials. Synthesis, antimalarial activity, and inhibition of haem polymerisation. Biochem. Pharmacol. 52: Rosenthal, P. J., and S. R. Meshnick Hemoglobin catabolism and iron utilisation by malaria parasites. Mol. Biochem. Parasitol. 83: Schueler, F. W., and W. F. Cantrell Antagonism of the antimalarial action of chloroquine by ferrihaemate and a hypothesis for the mechanism of chloroquine resistance. J. Pharmacol. Exp. Ther. 143: Sherman, I. W Amino acid metabolism and protein synthesis in malarial parasites. Bull. W. H. O. 55: Sherman, I. W., and L. Tanigoshi Incorporation of 14 C-amino acids by malaria (Plasmodium lophurae). Int. J. Biochem. 1: Slater, A. F. G., and A. Cerami Inhibition by chloroquine of a novel haeme polymerase enzyme activity in malaria trophozoites. Nature 355: Ward, S. A., P. G. Bray, and S. R. Hawley Quinoline resistance mechanisms in Plasmodium falciparum: the debate goes on. Parasitology 114:S125 S Zarchin, S., M. Krugliak, and H. Ginsburg Digestion of the host erythrocyte by malarial parasites is the primary target for quinoline-containing antimalarials. Biochem. Pharmacol. 35:
In vitro Studies into the Genetic Basis of Drug Resistance in Plasmodium falciparum
In vitro Studies into the Genetic Basis of Drug Resistance in Plasmodium falciparum David A. Fidock, Ph.D. Depts. of Microbiology and Medicine Columbia University MMV Symposium, ASMTH, Nov. 4, 2007 Global
More informationUse of the NP-40 Detergent-Mediated Assay in Discovery of Inhibitors of -Hematin Crystallization
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, July 2011, p. 3363 3369 Vol. 55, No. 7 0066-4804/11/$12.00 doi:10.1128/aac.00121-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. Use of
More informationTitle: In vitro antimalarial susceptibility and molecular markers of drug resistance in Franceville, Gabon
Author's response to reviews Title: In vitro antimalarial susceptibility and molecular markers of drug resistance in Franceville, Gabon Authors: Rafika ZATRA (rafika.zatra@hotmail.fr) Jean Bernard LEKANA-DOUKI
More informationSynchronisation of P. falciparum v1.1. Procedure. In vitro Module WorldWide Antimalarial Resistance Network (WWARN)
Synchronisation of P. falciparum v1.1 Procedure In vitro Module WorldWide Antimalarial Resistance Network (WWARN) Suggested citation: In vitro Module, WWARN. 2010. Synchronisation of P. falciparum. WWARN
More informationIn vitro Module WorldWide Antimalarial Resistance Network (WWARN)
V1.0 Procedure In vitro Module WorldWide Antimalarial Resistance Network (WWARN) Suggested citation: In vitro Module, WWARN 2011. P.falciparum drug sensitivity assay using SYBR Green I Assay Technique
More informationCytotoxicity LDH Assay Kit-WST
Cytotoxicity LDH Assay Kit-WST Supplementary Information Notice to Users Preparation of Reagent This instruction complements the Technical Manual in the product. Please use this instruction as supplements
More informationFlashPlate File #15. High Throughput Screening. J. Watson SmithKline Beecham Pharmaceuticals, UK.
Drug Discovery Research Clinical Screening High Throughput Screening FlashPlate File #15 Use of Novel FlashPlate Technology to Measure camp Accumulation in Chinese Hamster Ovary Cells Expressing Human
More informationIn Vitro Culture and Drug Sensitivity Assay of Plasmodium falciparum with Nonserum Substitute and Acute-Phase Sera
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 1999, p. 700 705 Vol. 37, No. 3 0095-1137/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. In Vitro Culture and Drug Sensitivity
More informationSUMOylated protein capture kit
SUMOylated protein capture kit Cat no. A010-100 Capture and detect SUMOylated proteins High capacity, high specificity SUMO binding matrix Fast, convenient protein isolation using purification system provided
More informationUse of the NP-40 Detergent Mediated Assay in the Discovery of Inhibitors of β-hematin Crystallization
AAC Accepts, published online ahead of print on 25 April 2011 Antimicrob. Agents Chemother. doi:10.1128/aac.00121-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationPaul Bowyer. (Baker Lab, London School of Hygiene and Tropical Medicine)
Evaluation of selective inhibitors of the malarial cyclic GMP dependent protein kinase (PKG) Paul Bowyer (Baker Lab, London School of Hygiene and Tropical Medicine) Talk summary An overview of the P. falciparum
More informationIDTox Lactate Dehydrogenase (LDH) Enzyme Cytotoxicity Kit For Cell Culture Supernatant Samples
Rev Date: Mar 26 2015 Rev: 1 1 of 1 IDTox Lactate Dehydrogenase (LDH) Enzyme Cytotoxicity Kit For Cell Culture Supernatant Samples 192 Wells Enzyme Immunoassay for the determination of the Lactate Dehydrogenase
More informationMedicines for Malaria Venture (MMV) Strategic Consultation POSITION PAPER EXPLORING COMBINATIONS OF ANTIMALARIAL DRUGS
Medicines for Malaria Venture (MMV) Strategic Consultation POSITION PAPER EXPLORING COMBINATIONS OF ANTIMALARIAL DRUGS Meeting held November 4 th 2007, Philadelphia, USA CHAIRMAN: Professor Marcel Tanner
More informationRat IGF-1 ELISA Kit (rigf-1-elisa)
Rat IGF-1 ELISA Kit (rigf-1-elisa) Cat. No. EK0377 96 Tests in 8 x 12 divisible strips Background Insulin-like growth factor 1 (IGF-1), also known as somatomedin C, is a polypeptide protein hormone similar
More informationRenaturation Basic Kit for Proteins
Renaturation Basic Kit for Proteins Product Number 96827 Store at 2-8 C Application The Renaturation Basic Kit for Proteins is a rapid empirical screening method used to determine the best conditions for
More informationab MDR Assay Kit (Fluorometric)
ab112142 MDR Assay Kit (Fluorometric) Instructions for Use For detecting MDR pump activities in cells using our proprietary fluorescence probe. This product is for research use only and is not intended
More informationNormalization of Agilent Seahorse XF Data by In-situ Cell Counting Using a BioTek Cytation 5
Normalization of Agilent Seahorse XF Data by In-situ Cell Counting Using a BioTek Cytation Application Note Authors Yoonseok Kam 1, Ned Jastromb 1, Joe Clayton, Paul Held, and Brian P. Dranka 1 1 Agilent
More informationLow cost and non-toxic genomic DNA extraction for use in molecular marker studies.
Low cost and non-toxic genomic DNA extraction for use in molecular marker studies. Version 1.4, February 28 th, 2013. Prepared by Bernhard Hofinger, Owen Huynh and Brad Till. 1. OBJECTIVE To develop and
More informationNew Quinoline Di-Mannich Base Compounds with Greater Antimalarial Activity than Chloroquine, Amodiaquine, or Pyronaridine
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, June 1997, p. 1369 1374 Vol. 41, No. 6 0066-4804/97/$04.00 0 Copyright 1997, American Society for Microbiology New Quinoline Di-Mannich Base Compounds with Greater
More informationWesternMAX Alkaline Phosphatase Chemiluminescent Detection Kits
WesternMAX Alkaline Phosphatase Chemiluminescent Detection Kits Code N221-KIT N220-KIT Description WesternMAX Chemiluminescent AP Kit, Anti-Mouse Includes: Alkaline Phosphatase (AP) Conjugated Anti-Mouse
More informationMouse Factor XII Total ELISA Kit
Mouse Factor XII Total ELISA Kit Catalog No: IMFXIIKT-TOT Lot No: SAMPLE INTENDED USE This mouse coagulation Factor XII antigen assay is intended for the quantitative determination of total Factor XII
More informationab65354 Superoxide Dismutase Activity Assay kit (Colorimetric)
Version 9 Last updated 11 January 2018 ab65354 Superoxide Dismutase Activity Assay kit (Colorimetric) For the measurement of Superoxide Dismutase Activity in various samples. This product is for research
More informationNEW INSIGHTS ON THE STRUCTURE-FUCTION PRINCIPLES & DESIGN OF QUINOLINE ANTIMALARIAL DRUGS
NEW INSIGHTS ON THE STRUCTURE-FUCTION PRINCIPLES & DESIGN OF QUINOLINE ANTIMALARIAL DRUGS A Dissertation submitted to the Faculty of the Graduate School of Arts and Sciences of Georgetown University in
More informationHuman TGF-beta1 ELISA
K-ASSAY Human TGF-beta1 ELISA For the quantitative determination of TGF-beta1 in human cell culture supernates, serum, plasma (EDTA) and urine Cat. No. KT-1471 For Research Use Only. Not for diagnostic
More informationSensoLyte Anti-alpha-Synuclein Quantitative ELISA Kit (Human/Mouse/Rat) *Colorimetric*
Catalog # Kit Size SensoLyte Anti-alpha-Synuclein Quantitative ELISA Kit (Human/Mouse/Rat) *Colorimetric* AS-55550 One 96-well strip plate This kit is optimized to detect human/mouse/rat alpha-synuclein
More informationHOST-VIRUS INTERACTIONS II. THE CI:I~,~EAL SIMULATION OF TIlE INTEP~ERENOE Pm~Nom~oN BY 5-METmZL TRXrPTOPRAm~
CHEMICAL STUDIES ON HOST-VIRUS INTERACTIONS II. THE CI:I~,~EAL SIMULATION OF TIlE INTEP~ERENOE Pm~Nom~oN BY 5-METmZL TRXrPTOPRAm~ BY SEYMOUR S. COHEN, Pw.D., ~ THOMAS F. ANDERSON, I~.D. (From the Department
More informationSilensomes CYP Phenotyping Kit Technical Information & Instructions
Lonza Walkersville, Inc. Walkersville, MD 21793-0127 USA U.S. Scientific Support: 800 521 0390 scientific.support@lonza.com EU/ROW Scientific Support: +32 87 321 611 scientific.support.eu@lonza.com Document
More informationPhosphate buffered saline (PBS) for washing the cells TE buffer (nuclease-free) ph 7.5 for resuspending the SingleShot RNA control template
Catalog # Description 172-5085 SingleShot SYBR Green Kit, 100 x 50 µl reactions For research purposes only. Introduction The SingleShot SYBR Green Kit prepares genomic DNA (gdna) free RNA directly from
More informationAnti-Asian Sea bass (Lates calcarifer) IgM monoclonal antibody labelled with horseradish peroxidase. Product no: C2-HRP
Anti-Asian Sea bass (Lates calcarifer) IgM monoclonal antibody labelled with horseradish peroxidase Product no: C2-HRP Product Description This monoclonal antibody (Mab) reacts with Asian Sea bass (Lates
More informationab GFP ELISA Kit Instructions for Use For the quantitative measurement of GFP protein expression
ab117992 GFP ELISA Kit Instructions for Use For the quantitative measurement of GFP protein expression This product is for research use only and is not for diagnostic use. intended www.abcam.com Table
More informationO-GlcNAcase Activity Assay
O-GlcNAcase Activity Assay Prepared by Jen Groves and Junfeng Ma, The Johns Hopkins Unviersity School of Medicine Based on: Macauley MS et al., 2005. O-GlcNAcase uses substrate-assisted catalysis: kinetic
More informationThe preparation of native chromatin from cultured human cells.
Native chromatin immunoprecipitation protocol The preparation of native chromatin from cultured human cells. All solutions need to be ice cold. Sucrose containing solutions must be made up fresh on the
More informationPorcine IgM (Immunoglobulin M) ELISA Kit
Porcine IgM (Immunoglobulin M) ELISA Kit Catalogue No: EP0085 Size: 48T/96T Reactivity: Porcine Detection Range: 0.156-10ng/ml Sensitivity:
More informationMouse ICAM-1 / CD54 ELISA Pair Set
Mouse ICAM-1 / CD54 ELISA Pair Set Catalog Number : SEK50440 To achieve the best assay results, this manual must be read carefully before using this product and the assay is run as summarized in the General
More informationab SIRT1 Activity Assay Kit (Fluorometric)
ab156065 SIRT1 Activity Assay Kit (Fluorometric) Instructions for Use For the quantitative measurement of SIRT1 activity in cell lysates This product is for research use only and is not intended for diagnostic
More informationUniversal Kinase Assay Kit (Fluorometric) For monitoring ADP formation, which is directly proportional to enzyme phosphotransferase activity
ab138879 Universal Kinase Assay Kit (Fluorometric) Instructions for Use For monitoring ADP formation, which is directly proportional to enzyme phosphotransferase activity This product is for research use
More informationHuman IL10RB ELISA Pair Set ( CRFB4 )
Human IL10RB ELISA Pair Set ( CRFB4 ) Catalog Number : SEK10945 To achieve the best assay results, this manual must be read carefully before using this product and the assay is run as summarized in the
More informationPROCEDURE FOR USE NICKEL NTA Magnetic Agarose Beads (5%)
1 AFFINITY HIS-TAG PURIFICATION PROCEDURE FOR USE NICKEL NTA Magnetic Agarose Beads (5%) DESCRIPTION Nickel NTA Magnetic Agarose Beads are products that allow rapid and easy small-scale purification of
More informationBiofilm Protocol Optimization For Pseudomonas aeruginosa. Introduction. Materials and Methods. Culture Media, Incubation Time, and Biofilm Measurement
Biofilm Protocol Optimization For Pseudomonas aeruginosa Culture Media, Incubation Time, and Biofilm Measurement Introduction In addition to the conventional arsenal of antibiotic resistance mechanisms
More informationMitochondria/Cytosol Fractionation Kit
Mitochondria/Cytosol Fractionation Kit Sufficient for analysis of 50 samples Cat. No. MIT1000 FOR RESEARCH USE ONLY Not for use in diagnostic procedures. USA & Canada Phone: +1(800) 437-7500 Fax: +1 (951)
More information1. Cross-linking and cell harvesting
ChIP is a powerful tool that allows the specific matching of proteins or histone modifications to regions of the genome. Chromatin is isolated and antibodies to the antigen of interest are used to determine
More informationABC. Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline. Volume 19 Number 18
M26-A ISBN 1-56238-384-1 September 1999 ISSN 0273-3099 Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline Volume 19 Number 18 Arthur L. Barry, Ph.D. William A. Craig,
More informationMalaria Research Capability Strengthening in Africa
July 2005 UNICEF/UNDP/World Bank/WHO Special Programme for Research & Training in Tropical Diseases (TDR) Multilateral Initiative on Malaria (MIM) Malaria Research Capability Strengthening in Africa INTRODUCTION
More informationHuman immunoglobulin G(IgG) ELISA Kit
Human immunoglobulin G(IgG) ELISA Kit For the quantitative determination of human immunoglobulin G (IgG) concentrations in serum, plasma, cell culture supernates, urine, tissue homogenates, cell lysates.
More informationPorcine Transferrin Receptor(TFR) ELISA Kit
Porcine Transferrin Receptor(TFR) ELISA Kit Catalog No. CSB-E13481p (96T) This immunoassay kit allows for the in vitro quantitative determination of porcine TFR concentrations in serum, plasma. Expiration
More informationMouse ALP (Alkaline Phosphatase) ELISA Kit
Mouse ALP (Alkaline Phosphatase) ELISA Kit Catalogue No.:MBS765655 Size:48T/96T Reactivity:Mouse Range:0.313-20ng/ml Sensitivity:
More informationProduct Development Partnership on Discovery and Development of Health Technologies
Product Development Partnership on Discovery and Development of Health Technologies Improving Access to Essential Health Technologies: Focusing on Neglected Diseases, Reaching Neglected Populations Prince
More informationCalcium Assay Kit. Technical Data Sheet. Product Information. Description. Storage. Materials not included
BD Technical Data Sheet Calcium Assay Kit Product Information Catalog Number: 640176 Size Reagents for 10 plates Components: Calcium Indicator, 1 vial, lyophilized 10X Signal Enhancer, 10 ml 1X Calcium
More informationDNAse I qualification and sample treatment
DNA Application Note DNAse I qualification and sample treatment INTRODUCTION The Threshold Total DNA Assay quantitates contaminant DNA in biopharmaceutical drugs. DNase I can be used in conjunction with
More informationVALIDATION GUIDE FOR CHROMOGENIC ASSAY FOR ACTIZYME Anti-FIIa
VALIDATION GUIDE FOR CHROMOGENIC ASSAY FOR ACTIZYME Anti-FIIa Chromogenic assay for testing heparins (UFH, LMWH and Enoxaparin) in purified systems by measurement of FIIa Inhibition, in compliance with
More informationNAD/NADH Cell-Based Assay Kit
NAD/NADH Cell-Based Assay Kit Item No. 600480 Customer Service 800.364.9897 * Technical Support 888.526.5351 www.caymanchem.com TABLE OF CONTENTS GENERAL INFORMATION 3 Materials Supplied 3 Safety Data
More informationAn indirect haemagglutination test to detect serum antibodies to Giardia lamblia
J. Biosci., Vol. 10, Number 4, December 1986, pp. 475-480. Printed in India. An indirect haemagglutination test to detect serum antibodies to Giardia lamblia K. N. JALAN, TUSHER MAITRA and RITA DAS Kothari
More informationNETosis Assay Kit. Item No Customer Service Technical Support
NETosis Kit Item No. 601010 www.caymanchem.com Customer Service 800.364.9897 Technical Support 888.526.5351 1180 E. Ellsworth Rd Ann Arbor, MI USA TABLE OF CONTENTS GENERAL INFORMATION 3 Materials Supplied
More informationData Sheet. Hippo Pathway TEAD Reporter MCF7 Cell Line Catalog #: 60618
Data Sheet Hippo Pathway TEAD Reporter MCF7 Cell Line Catalog #: 6618 Background The Hippo pathway regulates cell proliferation and cell death. It is activated by high cell density and cell stress to stop
More informationVZV Replication Assays Samantha J. Griffiths * and Jürgen Haas
VZV Replication Assays Samantha J. Griffiths * and Jürgen Haas Division of Pathway and Infection Medicine, University of Edinburgh, Edinburgh, UK *For correspondence: samantha.griffiths@ed.ac.uk [Abstract]
More informationCanine Creatinine(Cr) ELISA kit. Catalog No. MBS (96T)
Canine Creatinine(Cr) ELISA kit Catalog No. MBS704078 (96T) This immunoassay kit allows for the in vitro quantitative determination of canine Cr concentrations in serum, plasma and other biological fluids.
More informationab Factor IXa Activity Assay Kit (Fluorometric)
ab204727 Factor IXa Activity Assay Kit (Fluorometric) Instructions for Use For rapid, sensitive and accurate detection of Factor IXa activity. This product is for research use only and is not intended
More informationSupporting information. Single-cell and subcellular pharmacokinetic imaging allows insight into drug action in vivo
Supporting information Single-cell and subcellular pharmacokinetic imaging allows insight into drug action in vivo Greg Thurber 1, Katy Yang 1, Thomas Reiner 1, Rainer Kohler 1, Peter Sorger 2, Tim Mitchison
More informationopen access Hypothesis Volume 8(8) Rajani Kanta Mahapatra 1, 2 *, Niranjan Behera 1 & Pradeep Kumar Naik 3
www.bioinformation.net ypothesis Volume 8(8) Molecular modeling and evaluation of binding mode and affinity of artemisinin-quinine hybrid and its congeners with Fe-protoporphyrin-IX as a putative receptor
More informationE.Z.N.A. Blood DNA Maxi Kit. D preps D preps
E.Z.N.A. Blood DNA Maxi Kit D2492-00 2 preps D2492-03 50 preps April 2014 E.Z.N.A. Blood DNA Maxi Kit Table of Contents Introduction and Overview...2 Kit Contents/Storage and Stability...3 Preparing Reagents...4
More informationHuman Connective Tissue Growth Factor (CTGF) Elisa Kit
Human Connective Tissue Growth Factor (CTGF) Elisa Kit Catalog No. CSB-E07875h (96 tests) This immunoassay kit allows for the in vitro quantitative determination of human CTGF concentrations in serum,
More informationHuman IL-10 ELISA MAX Set Deluxe
Human IL-10 ELISA MAX Set Deluxe Cat. No. 430604 (5 plates) 430605 (10 plates) 430606 (20 plates) ELISA Set for Accurate Cytokine Quantification from Cell Culture Supernatant, Serum, Plasma or Other Body
More informationAssessment of Three In Vitro Tests and an In Vivo Test for Chloroquine Resistance in Plasmodium falciparum Clinical Isolates
JOURNAL OF CLINICAL MICROBIOLOGY, Jan. 1998, p. 243 247 Vol. 36, No. 1 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology Assessment of Three In Vitro Tests and an In Vivo Test for
More informationKILL-TIME STUDIES Antimicrobial Activity of EO H 2 O Using Clostridium difficile spores Test Solutions: Acidic H 2 O Submitted December 12, 2011
KILL-TIME STUDIES Antimicrobial Activity of EO H 2 O Using Clostridium difficile spores Test Solutions: Acidic H 2 O Submitted December 12, 2011 December 20, 2011 PREPARED FOR: Rob Dahl Viritec, LLC. BY:
More informationab Plasmin Activity Assay Kit (Fluorometric)
ab204728 Plasmin Activity Assay Kit (Fluorometric) Instructions for Use For rapid, sensitive and accurate detection of Plasmin activity. This product is for research use only and is not intended for diagnostic
More informationOPPF-UK Standard Protocols: Mammalian Expression
OPPF-UK Standard Protocols: Mammalian Expression Joanne Nettleship joanne@strubi.ox.ac.uk Table of Contents 1. Materials... 3 2. Cell Maintenance... 4 3. 24-Well Transient Expression Screen... 5 4. DNA
More informationSummary of Mutagenic Toxicity Test Results for EvaGreen
Summary of Mutagenic Toxicity Test Results for EvaGreen Compiled by Biotium, Inc. from the results of an independent testing service: Litron Laboratories, Inc., Rochester, NY Overview When our scientists
More informationHigh-Throughput Plasmodium falciparum Growth Assay for Malaria Drug Discovery
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 2007, p. 716 723 Vol. 51, No. 2 0066-4804/07/$08.00 0 doi:10.1128/aac.01144-06 Copyright 2007, American Society for Microbiology. All Rights Reserved. High-Throughput
More informationNADP+/NADPH Assay Kit
NADP+/NADPH Assay Kit Catalog Number KA1663 100 assays Version: 03 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle of the Assay...
More informationAFFINITY HIS-TAG PURIFICATION
DESCRIPTION Nickel NTA Agarose Cartridges 5ml are used for purification of histidine-tagged proteins in native or denaturing conditions. This cartridge can be used with an automated chromatography system,
More informationCalcein AM Cell Viability Kit
Instructions For Research Use Only. Not For Use In Diagnostic Procedures Calcein AM Cell Viability Kit Catalog# 4892-010-K 1000 Tests* * Calculated based on using 1 μm final concentration of Calcein AM;
More informationDiscovery and Humanization of Novel High Affinity Neutralizing Monoclonal Antibodies to Human IL-17A
Discovery and Humanization of Novel High Affinity Neutralizing Monoclonal Antibodies to Human IL-17A Contacts: Marty Simonetti martysimonetti@gmail.com Kirby Alton kirby.alton@abeomecorp.com Rick Shimkets
More informationEPIGENTEK. EpiQuik Histone Demethylase LSD1 Activity/Inhibition Assay Kit. Base Catalog # P-3076 PLEASE READ THIS ENTIRE USER GUIDE BEFORE USE
EpiQuik Histone Demethylase LSD1 Activity/Inhibition Assay Kit Base Catalog # PLEASE READ THIS ENTIRE USER GUIDE BEFORE USE The EpiQuik Histone Demethylase LSD1 Activity/Inhibition Assay Kit is very suitable
More informationStore samples to be assayed within 24 hours at 2-8 C. For long-term storage, aliquot and freeze samples at -20 C. Avoid repeated freeze-thaw cycles.
Human Retinol Binding Protein 4, RBP4 ELISA Kit Preparation Plate Washing Discard the solution in the plate without touching the side walls. Blot the plate onto paper towels or other absorbent material.
More informationTag-lite Tachykinin NK1 labeled Cells, ready-to-use (transformed & labeled), 200 tests* (Part# C1TT1NK1)
TAG - L I T E Tag-lite Tachykinin NK1 Receptor Ligand Binding Assay protocol Tachykinin NK1 labeled cells for: 200 tests Part#: C1TT1NK1 Lot#: 03-1 March 2016 (See expiration date on package label) Store
More informationMouse Heparan Sulfate(Heparan Sulfate) ELISA Kit
Mouse Heparan Sulfate(Heparan Sulfate) ELISA Kit Catalogue No.:EM1594 Size:48T/96T Reactivity: Mouse Range:31.25-2000ng/ml Sensitivity:
More informationZ -LYTE KINASE ASSAY KIT SER/THR 9 PEPTIDE PROTOCOL
Z -LYTE KINASE ASSAY KIT SER/THR 9 PEPTIDE PROTOCOL Part # PV3324 Lit. # 762-038412 020304 TABLE OF CONTENTS 1.0 INTRODUCTION... 2 2.0 ASSAY THEORY... 2 3.0 Z -LYTE KINASE ASSAY KIT SER/THR 9 PEPTIDE MATERIALS
More informationab Plasmin Inhibitor Screening Assay Kit (Fluorometric)
ab204729 Plasmin Inhibitor Screening Assay Kit (Fluorometric) Instructions for Use For rapid, sensitive and accurate screening of potential Plasmin inhibitors. This product is for research use only and
More informationNAG-1 (GDF-15, MIC-1) Prostate Cancer ELISA kit
NAG-1 (GDF-15, MIC-1) Prostate Cancer ELISA kit Catalog Number: NG1 Store at -0 C. FOR RESEARCH USE ONLY v. 1081 Introduction This sandwich ELISA kit is for determination of NAG-1 (GDF-15, MIC-1) levels
More informationab65354 Superoxide Dismutase Activity Assay kit (Colorimetric)
ab65354 Superoxide Dismutase Activity Assay kit (Colorimetric) Instructions for Use For the rapid, sensitive and accurate measurement of Superoxide Dismutase Activity in various samples. This product is
More informationHuman placenta lactogen (HPL) ELISA Kit
Human placenta lactogen (HPL) ELISA Kit Catalog Number. CSB-E09665h For the quantitative determination of human placenta lactogen (HPL) concentrations in serum, plasma. This package insert must be read
More informationCell Growth and DNA Extraction- Technion igem HS
Growing Cells and DNA Extraction Goals 1. Become familiar with the process of growing bacteria 2. Get to know the DNA extraction process 3. Perform miniprep in the lab Keywords 1. Growth stages 6. Techniques
More informationPI3 Kinase Assay Kit. Catalog Number KA assays Version: 05. Intended for research use only.
PI3 Kinase Assay Kit Catalog Number KA0904 400 assays Version: 05 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Background... 3 General Information... 4 Materials Supplied...
More informationBovine prolactin/luteotropic hormone (PRL/LTH) ELISA Kit
Bovine prolactin/luteotropic hormone (PRL/LTH) ELISA Kit Catalog Number. MBS703224 For the quantitative determination of bovine prolactin/luteotropic hormone (PRL/LTH) concentrations in serum, plasma.
More informationA Level. A Level Biology. Cells, Microscopes, Cell Cycle and Immunity Questions. AQA, OCR, Edexcel. Name: Total Marks: Page 1
AQA, OCR, Edexcel A Level A Level Biology Cells, Microscopes, Cell Cycle and Immunity Questions Name: Total Marks: Page 1 Q1.The diagram shows a eukaryotic cell. (a) Complete the table by giving the letter
More informationMouse TNF alpha ELISA Kit
Mouse TNF alpha ELISA Kit Catalog No. GWB-ZZD049 Size 96 wells/kit Sandwich ELISA kit for quantitative detection of mouse TNF alpha in cell culture supernates, serum and plasma(heparin, EDTA). Typical
More informationFor the rapid, sensitive and accurate measurement of Glutamate in various samples.
ab83389 Glutamate Assay Kit Instructions for Use For the rapid, sensitive and accurate measurement of Glutamate in various samples. This product is for research use only and is not intended for diagnostic
More informationIMMUNOPRECIPITATION (IP)
1 IMMUNOPRECIPITATION (IP) Overview and Technical Tips 2 CONTENTS 3 7 8 9 12 13 17 18 19 20 Introduction Factors Influencing IP General Protocol Modifications Of IP Protocols Troubleshooting Contact Us
More informationEdU Flow Cytometry Kit. User Manual
User Manual Ordering information: (for detailed kit content see Table 2) EdU Flow Cytometry Kits for 50 assays: Product number EdU Used fluorescent dye BCK-FC488-50 10 mg 6-FAM Azide BCK-FC555-50 10 mg
More informationBovine Prostaglandin E2 (PG-E2) ELISA Kit
Bovine Prostaglandin E2 (PG-E2) ELISA Kit Catalog Number. CSB-E14237B For the quantitative determination of endogenic bovine prostaglandin E2 (PG-E2) concentrations in serum, plasma, tissue homogenates.
More informationINOS. Colorimetric Cell-Based ELISA Kit. Catalog #: OKAG00807
INOS Colorimetric Cell-Based ELISA Kit Catalog #: OKAG00807 Please read the provided manual entirely prior to use as suggested experimental protocols may have changed. Research Purposes Only. Not Intended
More informationOpen clinical trial: Plasma levels of artemether and dihydroartemisinin for two commercially available artemether intramuscular injections.
Open clinical trial: Plasma levels of artemether and dihydroartemisinin for two commercially available artemether intramuscular injections. Principal investigator: L. K. Penali. Abstract To 23 patients
More informationTECHNICAL BULLETIN. In Vitro Bacterial Split Fluorescent Protein Fold n Glow Solubility Assay Kits
In Vitro Bacterial Split Fluorescent Protein Fold n Glow Solubility Assay Kits Catalog Numbers APPA001 In Vitro Bacterial Split GFP "Fold 'n' Glow" Solubility Assay Kit (Green) APPA008 In Vitro Bacterial
More informationGlutamate Assay Kit. Catalog Number KA assays Version: 03. Intended for research use only.
Glutamate Assay Kit Catalog Number KA1670 100 assays Version: 03 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 General Information...
More informationTyrosine Kinase Assay Kit, Red*
Rh Tyrosine Kinase Assay Kit, Red* 1.0 INTRODUCTION Part # P2882, P2883 Lit. # L0531 Rev. 11/02 Page 1 of 6 The phosphorylation of proteins by protein tyrosine kinases (PTKs) is critical to the normal
More informationab Factor Xa Inhibitor Screening Assay Kit (Fluorometric)
ab204712 Factor Xa Inhibitor Screening Assay Kit (Fluorometric) Instructions for Use For rapid, sensitive and accurate screening of potential Factor Xa inhibitors. This product is for research use only
More informationTechnical Note Detection of post-immunoprecipitation proteins by Western blot using the Quick Western Kit IRDye 680RD
Technical Note Detection of post-immunoprecipitation proteins by Western blot using the Quick Western Kit IRDye 680RD Developed for: Aerius, Odyssey Classic, Odyssey CLx and Odyssey Sa Imaging Systems
More informationImmuLux Human IL-6 Fluorescent ELISA Kit
INSTRUCTIONS ImmuLux Human IL- Fluorescent ELISA Kit 3747 N. Meridian Road P.O. Box 7 Rockford, IL 05 840 53w Product Description Number Description 840 ImmuLux Human IL- Fluorescent ELISA Kit The Pierce
More informationHuman immunoglobulin G(IgG) ELISA Kit
Human immunoglobulin G(IgG) ELISA Kit Catalog Number. CSB-E07979h For the quantitative determination of human immunoglobulin G (IgG) concentrations in serum, plasma, cell culture supernates, urine, tissue
More information